Integra Lifesciences Holdings Corp (NASDAQ:IART) shares traded 0.51% higher at $15.83 on Wall Street last session.
IART stock price is now -27.40% away from the 50-day moving average and -29.66% away from the 200-day moving average. The market capitalization of the company currently stands at $1.22B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On December 02, 2024, Morgan Stanley recently initiated its ‘Underweight’ rating on the stock quoting a target price of $20, while ‘BTIG Research’ rates the stock as ‘Neutral’
In other news, Schwartz Eric, EVP, Chief Legal Officer & Sec sold 4,070 shares of the company’s stock on Dec 03 ’24. The stock was sold for $100,102 at an average price of $24.59. Upon completion of the transaction, the EVP, Chief Legal Officer & Sec now directly owns 59,511 shares in the company, valued at $0.94 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 03 ’24, Officer Schwartz Eric bought 4,070 shares of the business’s stock. A total of $100,102 was incurred on buying the stock at an average price of $24.59. A total of 14.38% of the company’s stock is owned by insiders.
During the past 12 months, Integra Lifesciences Holdings Corp has had a low of $15.51 and a high of $32.66. As of last week, the company has a debt-to-equity ratio of 1.28, a current ratio of 1.17, and a quick ratio of 0.71. The fifty day moving average price for IART is $21.8054 and a two-hundred day moving average price translates $22.5047 for the stock.
The latest earnings results from Integra Lifesciences Holdings Corp (NASDAQ: IART) was released for 2024-12-31. The net profit margin was -0.43% and return on equity was -0.44% for IART. The company reported revenue of $442.65 million for the quarter, compared to $397.04 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 11.49 percent.
